-+ 0.00%
-+ 0.00%
-+ 0.00%

Turn Therapeutics to host webcast on GX-03 atopic dermatitis Phase 2 interim analysis

PUBT·07/06/2026 20:01:13
Listen to the news
Turn Therapeutics to host webcast on GX-03 atopic dermatitis Phase 2 interim analysis
  • Turn Therapeutics scheduled a live webcast for July 7, 2026, at 4:30 p.m. ET to present interim Phase 2 GX-03 atopic dermatitis data.
  • Management plans to outline the optimized Stage 2 trial design; webcast link: https://edge.media-server.com/mmc/p/jix773zk.
  • Press release planned for July 6, 2026, covering interim findings and the Stage 2 design.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Turn Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607061601BIZWIRE_USPR_____20260706_BW925902) on July 06, 2026, and is solely responsible for the information contained therein.